Zobrazeno 1 - 7
of 7
pro vyhledávání: '"K. W. Borch"'
Publikováno v:
Acta Radiologica. 40:291-295
Purpose: To compare iodixanol 270 mg I/ml with iohexol 300 mg I/ml in infrapopliteal arteriography by measuring digital densitometric vessel opacification and by visually assessing angiographic enhancement. Material and Methods: In a double-blind, du
Autor:
B. Lundby, J.Ø. Nossen, N.P. Jørgensen, D.T. Kristoffersen, A.B. Kristiansen, K. W. Borch, L. Theodorsen
Publikováno v:
European Journal of Radiology. 15:252-257
The low osmolar, non-ionic X-ray contrast media have shown a lower frequency of adverse events than the older ionic ones. In this study changes in routine clinical-chemical parameters in blood and urine, vital signs and adverse events were recorded i
Autor:
Nossen Jo, Y. F. Kloster, B. Bolstad, B. Lundby, D.T. Kristoffersen, E Andrew, B. H. Grynne, K. W. Borch
Publikováno v:
Investigative Radiology. 26:S201-S204
Publikováno v:
Journal de radiologie. 80(7)
To evaluate and compare in a double-blinded and prospective study the incidence of adverse reactions between two contrast agents used for coronary angiography and ventriculography. The first agent was the non-ionic, dimeric, isotonic contrast medium
Autor:
K. W. Borch, Hannu Manninen, Pekka J. Matsi, Matti Suhonen, Seppo Soimakallio, T. Wallen, K. Tahvanainen
Publikováno v:
European Radiology. 5
Iodixanol (320 mg I/ml) was compared with iopromide (370 mg I/ml) in a double-masked, parallel group, randomised trial of 120 patients undergoing cardioangiography in order to evaluate and compare safety, tolerability and radiographic efficacy. The o
Publikováno v:
Acta radiologica. Supplementum. 399
The results are reviewed from 18 European clinical vascular studies in 1950 patients where iodixanol (Visipaque) - a new isotonic, dimeric, nonionic contrast medium (CM) - is compared to other CM. Visipaque gave better patient comfort, i.e., less pai
Publikováno v:
Radiology. 182(2)
A new nonionic dimeric contrast medium (CM), iodixanol, was intravenously administered to 40 healthy male volunteers in doses of 0.3-1.2 g of iodine per kilogram of body weight, nonionic monomeric iopamidol and iopentol were administered to 20 others